Literature DB >> 2350617

Bone metabolism in juvenile rheumatoid arthritis.

M L Bianchi1, M Bardare, M P Caraceni, E Cohen, S Falvella, M Borzani, M G DeGaspari.   

Abstract

Plasma and urinary indexes of bone metabolism were studied in 36 children affected by juvenile rheumatoid arthritis (JRA) during 1 year, in order to evaluate the calciotropic hormone levels and bone mass. Children were divided in three groups according to the subtype of JRA: pauciarticular, polyarticular, systemic. Patients of the latter two groups were on corticosteroid treatment. A control group of healthy children (matched for age and sex) was compared. Children affected by pauciarticular disease did not show any difference with respect to controls. In the polyarticular and systemic groups, basal observation revealed decreased levels of 25(OH)D, significantly lower (P less than 0.01) with respect to the control and pauciarticular groups. After one year, 25(OH)D showed a further decrease in the systemic group, while PTH levels were increased. Moreover, bone mineral density values in systemic JRA were significantly lower than values of a matched control group and did not increase as expected during the year. It seems thus possible that severe JRA has an influence on bone mass, perhaps mediated by a decrease in active vitamin D metabolites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350617     DOI: 10.1016/0169-6009(90)90081-p

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  10 in total

Review 1.  What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence.

Authors:  Muhammad K Nisar; Falak Masood; Paul Cookson; Alison Sansome; Andrew J K Ostör
Journal:  Clin Rheumatol       Date:  2013-01-08       Impact factor: 2.980

2.  25-hydroxyvitamin D levels and juvenile idiopathic arthritis: is there an association with disease activity?

Authors:  Christina F Pelajo; Jorge M Lopez-Benitez; David M Kent; Lori Lyn Price; Laurie C Miller; Bess Dawson-Hughes
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

3.  Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis.

Authors:  Reyhan Celiker; Serpil Bal; Aysin Bakkaloğlu; Eda Ozaydin; Turgay Coskun; Alp Cetin; Fitnat Dinçer
Journal:  Rheumatol Int       Date:  2003-03-12       Impact factor: 2.631

4.  Growth and bone mineralization in patients with juvenile idiopathic arthritis.

Authors:  Ozgur Okumus; Muferet Erguven; Murat Deveci; Oznur Yilmaz; Mine Okumus
Journal:  Indian J Pediatr       Date:  2008-03       Impact factor: 1.967

5.  Bone turnover is reduced in children with juvenile rheumatoid arthritis.

Authors:  F Falcini; M Ermini; F Bagnoli
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

Review 6.  Vitamin D Supplementation in Patients with Juvenile Idiopathic Arthritis.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Shue-Fen Luo; Jing-Long Huang; Jenn-Haung Lai
Journal:  Nutrients       Date:  2022-04-07       Impact factor: 6.706

7.  Prevalence of Vitamin D Deficiency in Patients Treated for Juvenile Idiopathic Arthritis and Potential Role of Methotrexate: A Preliminary Study.

Authors:  Maciej K Stawicki; Paweł Abramowicz; Adrian Góralczyk; Justyna Młyńczyk; Anna Kondratiuk; Jerzy Konstantynowicz
Journal:  Nutrients       Date:  2022-04-14       Impact factor: 6.706

8.  Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review.

Authors:  Yosef Uziel; Eyal Zifman; Philip J Hashkes
Journal:  Pediatr Rheumatol Online J       Date:  2009-10-16       Impact factor: 3.054

Review 9.  Vitamin D and juvenile idiopathic arthritis.

Authors:  Sarah L Finch; Alan M Rosenberg; Hassan Vatanparast
Journal:  Pediatr Rheumatol Online J       Date:  2018-05-16       Impact factor: 3.054

10.  The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial.

Authors:  Madeleine Rooney; Nick Bishop; Joyce Davidson; Michael W Beresford; Clarissa Pilkington; Janet Mc Donagh; Sue Wyatt; Janet Gardner-Medwin; Rangaraj Satyapal; Jacqui Clinch; Helen Foster; Mark Elliott; Rejina Verghis
Journal:  EClinicalMedicine       Date:  2019-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.